Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000700025 | SCV000828761 | uncertain significance | Pierson syndrome; LAMB2-related infantile-onset nephrotic syndrome | 2022-07-11 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 577310). This variant has not been reported in the literature in individuals affected with LAMB2-related conditions. This variant is present in population databases (rs149653966, gnomAD 0.2%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 982 of the LAMB2 protein (p.Arg982Gln). |
Fulgent Genetics, |
RCV000700025 | SCV002779783 | uncertain significance | Pierson syndrome; LAMB2-related infantile-onset nephrotic syndrome | 2022-03-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003953244 | SCV004777355 | likely benign | LAMB2-related condition | 2022-03-21 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |